| Q78214029 | 100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience |
| Q43781337 | A standardized definition of ischemic cardiomyopathy for use in clinical research |
| Q43711816 | Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. |
| Q46028541 | Accurate measures of left ventricular ejection fraction using electron beam tomography: a comparison with radionuclide angiography, and cine angiography. |
| Q43975579 | Acute heart failure: determinants of outcome |
| Q28335541 | Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction |
| Q39460919 | Adverse effects associated with the newer inotropic agents |
| Q77178197 | Alteration of the alveolar-capillary membrane diffusing capacity in chronic left heart disease |
| Q37060322 | Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial |
| Q39649936 | Arrhythmias, catecholamines and electrolytes |
| Q34000206 | Assessing cardiac pumping capability by exercise testing and inotropic stimulation |
| Q93617320 | Association of digitalis therapy with mortality in survivors of acute myocardial infarction: observations in the Beta-Blocker Heart Attack Trial |
| Q72034303 | Beneficial clinical effect of very early enalapril treatment in patients with acute left ventricular failure complicating myocardial infarction |
| Q44263753 | Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study |
| Q38952140 | Calcium antagonists and chronic cardiac failure |
| Q36753945 | Captopril in heart failure. A double blind controlled trial |
| Q93530218 | Cardiac assistance with electrically stimulated skeletal muscle |
| Q69890605 | Cardiac pumping capability and prognosis in heart failure |
| Q68035369 | Cardiac transplantation: clinical aspects of recipient selection |
| Q73318627 | Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited |
| Q39659387 | Cardiovascular disease in the elderly. Heart failure |
| Q33614496 | Changing mortality in dilated cardiomyopathy. The Heart Muscle Disease Study Group. |
| Q36753619 | Circulating multimarker profile of patients with symptomatic heart failure supports enhanced fibrotic degradation and decreased angiogenesis |
| Q43754539 | Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy. |
| Q73746098 | Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy |
| Q34118183 | Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure |
| Q67898108 | Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care |
| Q73941222 | Comparison of echocardiography and electron beam tomography in differentiating the etiology of heart failure |
| Q50916056 | Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. |
| Q35575124 | Comparison of the electrocardiographic features of complete left bundle branch block in patients with ischemic and nonischemic left ventricular dysfunction. |
| Q54332987 | Comparison of three methods of electrical stimulation for converting skeletal muscle to a fatigue resistant power source suitable for cardiac assistance. |
| Q44414930 | Congestive heart failure symptoms in patients with preserved left ventricular systolic function: Analysis of the CASS registry |
| Q35157471 | Coronary by-pass for bad ventricle; adoption of "hybrid-pump" bypass |
| Q30459940 | Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy |
| Q37781700 | Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy |
| Q35350198 | Current issues in advanced heart failure |
| Q72809883 | Current problems in hypertension |
| Q73128340 | Decreased soluble interleukin-6 receptor in patients with acute myocardial infarction |
| Q44289894 | Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients |
| Q47895943 | Determinants of pulmonary hypertension in left ventricular dysfunction |
| Q72074937 | Device Use Patterns and Clinical Outcome of Implantable Cardioverter Defibrillator Patients with Moderate and Severe Impairment of Left Ventricular Function |
| Q41140592 | Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure |
| Q83426783 | Diagnostic performance of computed tomography angiography for differentiating ischemic vs nonischemic cardiomyopathy |
| Q73008868 | Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure |
| Q57259671 | Differential clinical prognostic classifications in dilated and ischemic adbanced heart failure: The EPICAL study |
| Q46080149 | Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography |
| Q78108731 | Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction |
| Q36759777 | Drug treatment of heart failure |
| Q42228756 | Dual source computed tomography coronary angiography in new onset cardiomyopathy |
| Q37932385 | Early intervention in heart failure |
| Q41227083 | Effect of acute hemodynamic decompensation on electrical inducibility of ventricular arrhythmias in patients with dilated cardiomyopathy and complex nonsustained ventricular arrhythmias |
| Q52331522 | Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine pilot study of sudden death and amiodarone (EPAMSA) |
| Q73189658 | Effect of phenylephrine with and without atropine on QT dispersion in healthy normotensive men |
| Q74822900 | Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic model |
| Q36760112 | Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state |
| Q70174526 | Effects of enalapril on different aspects of the clinical state in congestive heart failure |
| Q43892104 | Effects of prehospital medications on mortality and length of stay in congestive heart failure |
| Q54409186 | Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study. |
| Q67485411 | Estimating severity of chronic heart failure: A clinical challenge for the 1990s |
| Q61716910 | Etiology and response to drug treatment in heart failure |
| Q71328286 | Evaluating the efficacy of new inotropic agents |
| Q44684638 | Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods. |
| Q43645092 | Evidence based medical treatment of heart failure |
| Q67927748 | Evidence of a Selective Increase in Cardiac Sympathetic Activity in Patients with Sustained Ventricular Arrhythmias |
| Q77779884 | Ex-vivo mitral valve repair prior to orthotopic cardiac transplantation |
| Q35843144 | Exercise capacity in chronic heart failure is related to the aetiology of heart disease. |
| Q41381394 | Exercise for patients with congestive heart failure |
| Q71344696 | Exercise testing in chronic congestive heart failure |
| Q69810564 | Factors discriminating survivors and nonsurvivors in alcoholic heart disease |
| Q34117868 | Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure |
| Q43788569 | Failure to precondition pathological human myocardium |
| Q68128797 | Heart failure in a district general hospital |
| Q73290222 | Heart failure in patients seeking medical help at outpatients clinics. Part I. General characteristics |
| Q34797442 | Heart transplantation for dilated cardiomyopathy |
| Q54474048 | Hemodynamic effects of vasodilators and long-term response in heart failure |
| Q73853044 | Histological remodeling in an ovine heart failure model resembles human ischemic cardiomyopathy |
| Q33306751 | How would terminally ill patients have others make decisions for them in the event of decisional incapacity? A longitudinal study |
| Q35794539 | I Brazilian Registry of Heart Failure - Clinical Aspects, Care Quality and Hospitalization Outcomes |
| Q38145205 | Identification and management of potential heart transplant recipients. |
| Q40602720 | Identification and management of the high risk patient with dilated cardiomyopathy |
| Q44698178 | Idiopathic dilated cardiomyopathy in an Omani population of the Arabian Peninsula: prevalence, clinical profile and natural history |
| Q47914321 | Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history |
| Q39141583 | Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials. |
| Q74609155 | Improved outcomes from a comprehensive management system for heart failure |
| Q57259676 | Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study |
| Q74635675 | Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction |
| Q71807633 | Influence of the Implantable Cardioverter/Defibrillator on Sudden Death and Total Mortality in Patients Evaluated for Cardiac Transplantation |
| Q67924004 | Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendan |
| Q50068725 | Invasive testing in congestive heart failure |
| Q52219490 | Is cardiopulmonary resuscitation training deleterious for family members of cardiac patients? |
| Q38951649 | Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering? |
| Q59684598 | Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure |
| Q35582892 | Limited long term effects of a management programme for heart failure |
| Q50545942 | Long-Term Treatment of Ventricular Tachycardia with Amiodarone in Presence of Severe Left Ventricular Dysfunction |
| Q44136289 | Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy |
| Q36847784 | Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular function |
| Q54328586 | Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. |
| Q67289472 | MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response |
| Q69495372 | Management of arrhythmias in heart failure |
| Q39247532 | Marital status as a predictor of survival in idiopathic dilated cardiomyopathy: the Washington, DC dilated cardiomyopathy study |
| Q95817911 | Measurement of the quality of life in congestive heart failure-Influence of drug therapy |
| Q73568420 | Mechanisms and immediate outcome of in-hospital cardiac arrest in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy |
| Q54465891 | Mechanisms of compensation and decompensation in dilated cardiomyopathy. |
| Q33558612 | Medical management of congestive heart failure. |
| Q77802846 | Medical therapy of chronic heart failure. Role of ACE inhibitors and beta-blockers |
| Q34118615 | Mortality in heart failure: clinical variables of prognostic value |
| Q34272687 | Myocardial revascularization as a therapeutic strategy in the patient with advanced ventricular dysfunction |
| Q72748515 | Myocardial revascularization in the patient with severe left ventricular dysfunction |
| Q36123746 | Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? |
| Q81471989 | Nontransplant surgical alternatives for heart failure |
| Q68603592 | Optimization of pulse train duration for the electrical stimulation of a skeletal muscle ventricle in the dog |
| Q33610898 | Overnight studies in severe chronic left heart failure: arrhythmias and oxygen desaturation |
| Q35088168 | Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? |
| Q39440676 | Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia |
| Q39828505 | Potential uses of skeletal muscle for myocardial assistance. |
| Q54162146 | Prediction of long-term survival by preoperative exercise testing in patients with depressed ejection fraction undergoing myocardial revascularization. |
| Q34118481 | Prediction of outcome in dilated cardiomyopathy |
| Q68764972 | Prediction of outcome in late-stage cardiomyopathy |
| Q44217420 | Predictors of cause-specific hospital readmission in patients with heart failure |
| Q40751586 | Predictors of mortality in patients with heart failure. |
| Q71948926 | Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: Importance of β-blockade |
| Q67746743 | Predictors of prognosis in severe chronic heart failure |
| Q73108703 | Predictors of sudden death and death from pump failure in congestive heart failure are different. Analysis of 24 h Holter monitoring, clinical variables, blood chemistry, exercise test and radionuclide angiography |
| Q60607121 | Preoperative Positron Emission Tomographic Viability Assessment and Perioperative and Postoperative Risk in Patients With Advanced Ischemic Heart Disease |
| Q68215060 | Prevalence and mortality rate of congestive heart failure in the United States |
| Q43725551 | Prevalence of myocardial ischemia as depicted by regional wall motion abnormality in blacks. |
| Q35120857 | Prevention and management of chronic heart failure in patients at risk |
| Q41653923 | Primary prevention of sudden cardiac death in heart failure: will the solution be shocking? |
| Q34239867 | Prognosis determination in heart failure |
| Q68429000 | Prognosis of congestive heart failure and predictors of mortality |
| Q52952690 | Prognosis of idiopathic dilated cardiomyopathy. |
| Q38730614 | Prognostic factors affecting diagnosis and treatment of congestive heart failure |
| Q35398726 | Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation |
| Q68204869 | Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction |
| Q69747240 | Prognostic significance of 24-hour ambulatory electrocardiographic monitoring in patients with dilative cardiomyopathy: a prospective study |
| Q50870139 | Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure. |
| Q70614429 | Prognostic significance of electrocardiographic findings in patients with dilated cardiomyopathy |
| Q69653972 | Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias |
| Q74773953 | Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients |
| Q35135988 | Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? |
| Q72071078 | Reduction of exercise-induced ventricular arrhythmias in mild symptomatic heart failure by benazepril |
| Q71008947 | Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy |
| Q73370421 | Relation of daily activity levels in patients with chronic heart failure to long-term prognosis |
| Q36307927 | Relationship of the implantable cardioverter defibrillator and chronic resynchronization therapy: the perfect marriage? |
| Q35836645 | Response of the border zone to myocardial infarction in rats |
| Q41732517 | Restoring function in failing hearts: the effects of beta blockers |
| Q39471049 | Results of Revascularization in Patients With Severe Left Ventricular Dysfunction |
| Q43457988 | Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%. |
| Q73492740 | Results of revascularization in patients with severe left ventricular dysfunction |
| Q57652973 | Revascularization in severe ventricular dysfunction (15% ≤ LVEF ≤ 30%): a comparison of bypass grafting and percutaneous intervention |
| Q50863751 | Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling. |
| Q37296412 | Risks and benefits of the treatment of heart failure. Current status |
| Q59712598 | Role of the etiology of cardiomyopathies on exercise capacity and oxygen consumption in patients with severe congestive heart failure |
| Q74019545 | Safety and efficacy of automatic implantable defibrillator used as a bridge to heart transplant |
| Q35724692 | Selection of patients and techniques of heart transplantation |
| Q74267626 | Serial exercise testing and prognosis in selected patients considered for cardiac transplantation |
| Q33612622 | Shortened left ventricular filling time in dilated cardiomyopathy: additional effects on heart rate variability? |
| Q68912691 | Skeletal muscle ventricles for total heart replacement |
| Q33591383 | Sudden death in dilated cardiomyopathy |
| Q34052070 | Sudden death in heart failure patients: effects of optimized medical therapy |
| Q73592657 | Surgical Remodeling in Ischemic Cardiomyopathy |
| Q34443770 | Surgical treatments for heart failure |
| Q39386857 | Survival after myocardial revascularization for ischemic cardiomyopathy: a prospective ten-year follow-up study |
| Q67685486 | Survival in Patients with Depressed Left Ventricular Function Treated by Implantable Cardioverter Defibrillator |
| Q43488442 | Survival of patients with severe congestive heart failure treated with oral milrinone |
| Q35373046 | Ten year survival after heart transplantation: palliative procedure or successful long term treatment? |
| Q50546390 | The Natural History of Dilated Cardiomyopathy — A Community Study |
| Q39543930 | The multifacetted role of angiotensin converting enzyme inhibitors in congestive heart failure |
| Q39240823 | The natural history of isolated left ventricular diastolic dysfunction |
| Q39511387 | The role of exercise testing in chronic heart failure |
| Q33823518 | The role of exercise testing in the evaluation and management of heart failure |
| Q36551979 | Therapy of idiopathic dilated cardiomyopathy with chronic β-adrenergic blockade |
| Q44538367 | Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction. |
| Q74635651 | Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure |
| Q33758100 | Tolerability of extended duration intravenous milrinone in patients hospitalized for advanced heart failure and the usefulness of uptitration of oral angiotensin-converting enzyme inhibitors |
| Q42978754 | Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension |
| Q77535873 | Usefulness of electron beam computed tomography scanning for distinguishing ischemic from nonischemic cardiomyopathy |
| Q43604514 | Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction |
| Q40091787 | Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism |
| Q36303988 | Ventricular arrhythmia in congestive heart failure |
| Q38365097 | Ventricular arrhythmias in congestive heart failure |
| Q34421966 | Wasting as independent risk factor for mortality in chronic heart failure |
| Q36660382 | When is drug therapy warranted to prevent sudden cardiac death? |
| Q37018710 | When patients lack capacity: the roles that patients with terminal diagnoses would choose for their physicians and loved ones in making medical decisions |
| Q26750663 | Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells |